Klaus-Peter Dieckmann
Overview
Explore the profile of Klaus-Peter Dieckmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
1621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dieckmann K, Hochmuth-Tisch J, Salzbrunn A, Matthies C, von Kopylow K, Wulfing C, et al.
Basic Clin Androl
. 2025 Feb;
35(1):7.
PMID: 39966729
Background: Sperm cryopreservation in patients with testicular germ cell tumours (GCTs) is traditionally performed after orchiectomy. But, some evidence suggests preoperative semen quality to be superior. We aimed to clarify...
2.
Belge G, Klemke M, Hansen B, Dumlupinar C, Igde A, Arnold D, et al.
J Cancer Res Clin Oncol
. 2025 Jan;
151(2):58.
PMID: 39888414
Purpose: microRNA-371a-3p (M371) is considered a highly sensitive and specific serum biomarker of testicular germ cell tumours (GCTs). However, little is known about the expression of M371 in nontesticular malignancies...
3.
Ruf C, Hochmuth-Tisch J, Salzbrunn A, Matthies C, Cordes T, von Kopylow K, et al.
Urol Int
. 2025 Jan;
:1-9.
PMID: 39761660
Introduction: Subfertility is a well-known aftermath of treatment of testicular germ cell tumours (GCTs). Growing evidence suggests reduced semen quality also before therapy. The present study aimed to evaluate pre-orchiectomy...
4.
Dieckmann K, Harms A, Belge G, Wulfing C
Urol Int
. 2024 Nov;
:1-4.
PMID: 39571541
Introduction: Bilateral testicular tumours occur in 3-5% of all cases with testicular neoplasms. In the majority of cases, histology of the two new growths is identical. The time interval between...
5.
Schoch J, Schmelz H, Dieckmann K, Nestler T
Aktuelle Urol
. 2024 Oct;
55(6):520-527.
PMID: 39442529
Germ cell tumors of the testis are the most common tumor entities in young men. Since the introduction of platinum-based chemotherapy in the 1970s, most patients can be cured despite...
6.
7.
Dieckmann K, Belge G
Aktuelle Urol
. 2024 Aug;
55(6):510-519.
PMID: 39134037
Testicular germ cell tumours (GCTs) represent a paradigm for the usefulness of serum tumour markers in clinical management of diseases. However, the tumour markers currently in use, beta human chorionic...
8.
Dieckmann K, Grobelny F, Soave A, Che Y, Nestler T, Matthies C, et al.
Eur Urol Focus
. 2024 May;
10(5):851-857.
PMID: 38729824
Background And Objective: Serum levels of microRNA-371a-3p (M371) represent a novel and sensitive biomarker of germ cell tumours (GCTs). This study analysed the utility of M371 to identify viable cancer...
9.
Angerer M, Hansen B, Wulfing C, Dieckmann K
Oncology
. 2024 May;
102(11):988-995.
PMID: 38710175
Introduction: Paraneoplastic hyperthyroidism (PH) has been reported in patients with testicular germ cell tumors (GCTs), sporadically. This disorder is caused by extremely elevated serum levels of beta-human chorionic gonadotropin (bHCG)....
10.
Dieckmann K, Tharun L, Angerer M, Harms A, Wulfing C
J Med Case Rep
. 2024 Feb;
18(1):71.
PMID: 38383445
Background: Sex cord gonadal stromal tumors compose less than 10% of all testicular neoplasms and consist of a variety of histological subtypes. In 2016, the World Health Organization introduced a...